Furukawa TA - Search Results

1

Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis.

Furukawa TA, Salanti G, Atkinson LZ, Leucht S, Ruhe HG, Turner EH, Chaimani A, Ogawa Y, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Suganuma A, Watanabe N, Stockton S, Geddes JR, Cipriani A. Furukawa TA, et al. BMJ Open. 2016 Jul 8;6(7):e010919. doi: 10.1136/bmjopen-2015-010919. BMJ Open. 2016. PMID: 27401359 Free PMC article.

2

Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review.

Furukawa TA, McGuire H, Barbui C. Furukawa TA, et al. BMJ. 2002 Nov 2;325(7371):991. doi: 10.1136/bmj.325.7371.991. BMJ. 2002. PMID: 12411354 Free PMC article. Review.

3

Imputing response rates from means and standard deviations in meta-analyses.

Furukawa TA, Cipriani A, Barbui C, Brambilla P, Watanabe N. Furukawa TA, et al. Int Clin Psychopharmacol. 2005 Jan;20(1):49-52. doi: 10.1097/00004850-200501000-00010. Int Clin Psychopharmacol. 2005. PMID: 15602117

4

Gradations of clinical severity and sensitivity to change assessed with the Beck Depression Inventory-II in Japanese patients with depression.

Hiroe T, Kojima M, Yamamoto I, Nojima S, Kinoshita Y, Hashimoto N, Watanabe N, Maeda T, Furukawa TA. Hiroe T, et al. Among authors: furukawa ta. Psychiatry Res. 2005 Jun 30;135(3):229-35. doi: 10.1016/j.psychres.2004.03.014. Psychiatry Res. 2005. PMID: 15996749

5

Fluoxetine versus other types of pharmacotherapy for depression.

Cipriani A, Brambilla P, Furukawa T, Geddes J, Gregis M, Hotopf M, Malvini L, Barbui C. Cipriani A, et al. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004185. doi: 10.1002/14651858.CD004185.pub2. Cochrane Database Syst Rev. 2005. PMID: 16235353 Free PMC article. Updated. Review.

6

Imputing missing standard deviations in meta-analyses can provide accurate results.

Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Furukawa TA, et al. J Clin Epidemiol. 2006 Jan;59(1):7-10. doi: 10.1016/j.jclinepi.2005.06.006. J Clin Epidemiol. 2006. PMID: 16360555

7

Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review.

Furukawa TA, Watanabe N, Churchill R. Furukawa TA, et al. Br J Psychiatry. 2006 Apr;188:305-12. doi: 10.1192/bjp.188.4.305. Br J Psychiatry. 2006. PMID: 16582055 Review.

8

Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia.

Furukawa TA, Watanabe N, Churchill R. Furukawa TA, et al. Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD004364. doi: 10.1002/14651858.CD004364.pub2. Cochrane Database Syst Rev. 2007. PMID: 17253502 Free PMC article. Review.

9

Association between unreported outcomes and effect size estimates in Cochrane meta-analyses.

Furukawa TA, Watanabe N, Omori IM, Montori VM, Guyatt GH. Furukawa TA, et al. JAMA. 2007 Feb 7;297(5):468-70. doi: 10.1001/jama.297.5.468-b. JAMA. 2007. PMID: 17284696 No abstract available.

10

Combination of psychotherapy and benzodiazepines versus either therapy alone for panic disorder: a systematic review.

Watanabe N, Churchill R, Furukawa TA. Watanabe N, et al. Among authors: furukawa ta. BMC Psychiatry. 2007 May 14;7:18. doi: 10.1186/1471-244X-7-18. BMC Psychiatry. 2007. PMID: 17501985 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

697 results

Search Page